Nautilus Biotechnology, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Nautilus Biotechnology, Inc. (NAUT) had Common Stock, Capital Shares Reserved for Future Issuance of 58.96 million shares as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-07-28
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 58.96M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 59.12M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 52.13M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 52.29M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 58.96M shares 10-Q · filed 2026-07-28 |
| 2026-03-31 | 59.12M shares 10-Q · filed 2026-04-28 |
| 2025-12-31 | 52.13M shares 10-Q · filed 2026-07-28 |
| 2025-09-30 | 52.29M shares 10-Q · filed 2025-10-28 |
| 2025-06-30 | 52.29M shares 10-Q · filed 2025-07-31 |
| 2025-03-31 | 52.45M shares 10-Q · filed 2025-04-29 |
| 2024-12-31 | 44.93M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 45.47M shares 10-Q · filed 2024-10-29 |
| 2024-06-30 | 45.63M shares 10-Q · filed 2024-07-30 |
| 2024-03-31 | 45.77M shares 10-Q · filed 2024-04-30 |
| 2023-12-31 | 38.46M shares 10-K · filed 2025-02-27 |
| 2023-09-30 | 38.59M shares 10-Q · filed 2023-10-31 |
| 2023-06-30 | 38.60M shares 10-Q · filed 2023-08-02 |
| 2023-03-31 | 38.66M shares 10-Q · filed 2023-05-02 |
| 2022-12-31 | 31.17M shares 10-K · filed 2024-02-28 |
| 2022-09-30 | 31.31M shares 10-Q · filed 2022-11-01 |
| 2022-06-30 | 31.47M shares 10-Q · filed 2022-08-02 |
| 2022-03-31 | 31.58M shares 10-Q · filed 2022-05-03 |
| 2021-12-31 | 24.28M shares 10-K · filed 2023-02-23 |
| 2021-09-30 | 24.41M shares 10-Q · filed 2021-11-02 |
| 2021-06-30 | 24.49M shares 10-Q · filed 2021-08-10 |
| 2020-12-31 | 59.73M shares 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |